All News Q-linea AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 08:59:38 03/05/2024 pm IST			5-day change	1st Jan Change
2.46 ^SEK	-3.72%		-25.34%	-33.51%

13/03	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
27/02	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea applies for a NTAP code for the US market	03/05	AQ
Q-linea signs evaluation contract with reference laboratory network in the US	02/05	AQ
Q-linea receives US FDA 510(k) clearance for the ASTar® System	26/04	AQ
Q-linea publish the Annual report for 2023	12/04	AQ
Q linea : Strong ASTar results presented at AMCLI	13/03	PU
Q-linea AB Presents Strong ASTar Results At AMCLI	13/03	CI
Q-linea participates in tender for rapid AST	05/03	AQ
Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024	27/02
Year-end report 1 January – 31 December 2023	27/02	AQ
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	27/02	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02	CI
Q-linea presents at AMCLI	15/02	AQ
Q-linea Presents at AMCLI	15/02	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	09/02	MT
Q-linea creates separate subsidiary for Podler	09/02	AQ
Q-linea signs agreement with logistics partner for the American market	08/02	AQ
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024	01/02	AQ
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	01/02	CI
Q-linea Lands First ASTar Order from Finnish Distributor	31/01	MT
Labema Oy places its first ASTar order	31/01	AQ

No results for this search